Live Breaking News & Updates on 024 Summit Therapeutics Inc

Summit Therapeutics Inc. (NASDAQ:SMMT) Q4 2023 Earnings Call Transcript February 20, 2024 Summit Therapeutics Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to Summit’s Fourth Quarter and Year End 2023 Earnings Call. [Operator Instructions] Please […] ....

United States , Czech Republic , Santa Monica , Dave Gancarz , Ankur Dhingra , European Lung Cancer Congress , Non English Speakers , Team Summit , Summit Therapeutics Inc , Bob Duggan , Maky Zanganeh , Summit Therapeutics , 024 Summit Therapeutics Inc , Lung Cancer , Ankur Dhingra , Non Small Cell Lung Cancer , Clinical Trials , Phase 3 Trials , Cancer Patients ,